Transforming medications into smart solutions means creating powerful drug-device combinations that leverage specific mechanisms of action (MOA).
Broadly, we can categorize smart medications into three levels: supportive (with some overlap with promotional labeling), adjacent treatment, and at the highest level, synergistic claims, where the drug and device work in concert for enhanced therapeutic impact.
Get in touch to schedule a tailored primer workshop for your team. Designed for Business Development professionals, we’ll translate the science and risks behind DTx and smart medication into strategic pathways. Discover new possibilities.
Learn even more: Let’s go nerdy
By integrating devices with therapies, we drive innovation, enhance patient outcomes, and create long-term value. Our modular approach allows for seamless adaptation, ensuring that your products meet regulatory standards while remaining flexible for future advancements.